Table 2.
Name of gene | Mouse gene ID | Human gene ID | Expression in HBs: fold change vs liver |
Association with shortened survival in human cancersa, b, c | |||
---|---|---|---|---|---|---|---|
Δ(90)+ YAPS127A | Δ(90)+ L30P/R3P | YAPS127A+ L30P/R3P | Δ(90)+ YAPS127A+ L30P/R3P | ||||
Slc22a7 | 108114 | 10864 | –25.69 | –7.41 | –13.99 | –109.62 | KIRC,b LIHCb |
Inmt | 21743 | 11185 | –10.55 | –5.52 | –3.85 | –31.22 | LIHCb |
Gas1 | 14451 | 2619 | –6.98 | –3.76 | –6.84 | –22.76 | THCA,a KIRC,a KIRP,a KICH,a COAD,a READ,a STADa |
Atp5kd | 11958 | 521 | –2.28 | –1.89 | –5.73 | –11.40 | |
Ttrd | 22139 | 7276 | –5.35 | –2.71 | –3.31 | –9.42 | |
Cmtm8 | 70031 | 152189 | –2.67 | –1.95 | –1.98 | –6.14 | KIRC,b KIRPb |
Ppdpfd | 66496 | 79144 | –2.16 | –1.89 | –2.51 | –3.74 | KIRP,b KICHb |
Camkk2d | 207565 | 10645 | –1.69 | –1.66 | –1.79 | –3.51 | |
Tmem65d | 74868 | 157378 | 2.08 | 1.82 | 1.99 | 2.95 | UCECa |
Tpm1d | 22003 | 7168 | 2.69 | 2.05 | 2.52 | 3.50 | BLCAa |
Tgfad | 21802 | 7039 | 2.12 | 2.33 | 2.62 | 3.98 | PAAD,a THCAa |
Tmpod | 21917 | 7112 | 2.91 | 1.67 | 2.71 | 4.25 | KIRP,a KICHa |
Garsd | 353172 | 2617 | 2.86 | 1.68 | 2.01 | 4.57 | KIRC,a KIRP,a KICH,a BLCA,a LIHC,a BRCAa |
Rock2d | 19878 | 9475 | 2.77 | 2.83 | 3.08 | 5.22 | KIRC,b KIRP,a KICHa |
Il22ra1d | 230828 | 58985 | 3.15 | 3.80 | 3.40 | 6.58 | |
Arhgef2d | 16800 | 9181 | 4.93 | 1.86 | 4.45 | 8.72 | KIRC,a KICH,a LIHCa |
Acot9d | 56360 | 23597 | 8.89 | 2.39 | 7.67 | 13.02 | LIHCa |
Pck2 | 74551 | 5106 | 6.95 | 2.22 | 6.22 | 15.99 | LIHCa |
Lgals3 | 16854 | 3958 | 7.06 | 2.34 | 8.42 | 18.40 | |
Uap1l1d | 227620 | 91373 | 15.51 | 6.65 | 16.40 | 23.67 | LIHC,a PAADb |
Serpine1 | 18787 | 5054 | 7.35 | 9.25 | 11.86 | 43.70 | KIRC,a KIRP,a KICH,a LIHC,a STAD,a HNSCa |
Igfbp1 | 16006 | 3484 | 58.42 | 12.80 | 31.41 | 132.32 | KIRC,a LUAD,a STADa |
NOTE. The 22 transcripts listed here are a subset of the original 41 “BYN” groups depicted in Figure 5F that remained after eliminating those that were not regulated in the same direction in each case or that were not also deregulated in tumors driven by other types of β-catenin mutations or in tumors arising from myc-/- and/or chrebp-/- hepatocytes.22
Up-regulated.
Down-regulated.
See Figure 6 for Kaplan-Meier survival curves.
Also deregulated by Δ(90)+YAPS127A+WT-NFE2L2 tumors.